[1]
|
K. F. Swaiman, “Hallervorden-Spatz Syndrome,” Pediatric Neurology, Vol. 25, No. 2, 2001, pp. 102-108.
doi:10.1016/S0887-8994(01)00253-3
|
[2]
|
M. Kyriagis, P. Grattan-Smith, A. Scheinberg, C. Teo, N. Nakaji and M. Waugh, “Status Dystonicus and Hallervorden-Spatz Disease: Treatment with Intrathecal Baclofen and Pallidotomy,” Journal of Paediatrics Child Health, Vol. 40, No. 5-6, 2004, pp. 322-325.
doi:10.1111/j.1440-1754.2004.00374.x
|
[3]
|
J. Hinkelbeim, A. Kalenka and M. Alb, “Anesthesia for Patients with Pantothenate-Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)—A Literature Review,” Acta Neuropsychiatrica, Vol. 18, No. 3-4, 2006, pp. 168-172. doi:10.1111/j.1601-5215.2006.00144.x
|
[4]
|
R. C. Roy, S. McLain, A. Wise and L. D. Shaffner, “Anesthetic Management of a Patient with Hallervorden-Spatz Disease,” Anesthesiology, Vol. 58, 1983, pp. 382-384. doi:10.1097/00000542-198304000-00017
|
[5]
|
M. T. Keegan, R. P. Flick, J. Y. Matsumoto, D. H. Davis and W. L. Lanier, “Anesthetic Management for Two-Stage Computer-Assisted, Stereotactic Thalamotomy in a Child with Hallervorden-Spatz Disease,” Journal of Neurosurgical Anesthesiology, Vol. 12, No. 2, 2000, pp. 107-111. doi:10.1097/00008506-200004000-00006
|
[6]
|
W. Halliday, “The Nosology of Hallervorden-Spatz disease,” Journal of the Neurological Sciences, Vol. 134, Supplement, 1995, pp. 84-91.
doi:10.1016/0022-510X(95)00212-K
|
[7]
|
S. J. Hayflick, S. K. Westaway, B. Levinson, B. Zhou, M. A. Johnson, K. H. Ching and J. Gitschier, “Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome,” The New England Journal of Medicne, Vol. 348, 2003, pp. 33-40. doi:10.1056/NEJMoa020817
|
[8]
|
S. Kapoor, K. Hortnagel, S. Gogia, R. Paul, V. Malhotra and A. Prakash, “Pantothenate Kinase Associated Neuro-degeneration (Hallervorden-Spatz Syndrome),” Indian Journal of Pediatrics, Vol. 72, 2005, pp. 261-263.
|
[9]
|
R. P. Guillerman, “The Eye-of-the-Tiger Sign,” Radiology, Vol. 217, 2000, pp. 895-896.
|
[10]
|
K. D. Sethi, R. J. Adams, D. W. Loring and T. El Gammal, “Hallervorden-Spatz Syndrome: Clinical and Magnetic Resonance Imaging Correlations,” Annals of Neurology, Vol. 24, No. 5, 1988, pp. 692-694.
doi:10.1002/ana.410240519
|
[11]
|
P. Mariotti, A. Fasano, M. F. Contarino, G. D. Marca, M. Piastra, O. Genovese, S. Pulitanò, A. Chiaretti and A. R. Bentivoglio, “Management of Status Dystonicus: Our Experience and Review of the Literature,” Movement Disorders, Vol. 22, No. 7, 2007, pp. 963-968.
doi:10.1002/mds.21471
|
[12]
|
E. C. Sheehy, P. Longhurst, D. Pool and M. Dandekar, “Self-Inflicted Injury in a Case of Hallervorden-Spatz Disease,” International Journal of Paediatric Dentistry, Vol. 9, No. 4, 1999, pp. 299-302.
doi:10.1111/j.1365-263X.1999.00149.x
|
[13]
|
I. Balas, N. Kovacs and K. Hollody, “Staged Bilateral Stereotactic Pallidothalamotomy for Life-Threatening Dystonia in a Child with Hallervorden-Spatz Disease,” Movement Disorders, Vol. 21, No. 1, 2006, pp. 82-85.
doi:10.1002/mds.20655
|
[14]
|
P. Hurtado, L. Salvador, E. Carrero, J. Rumia and N. Fabregas, “Anesthesia Considerations for Deep-Brain Stimulation in a Patient with Type-2 Pantothenate Kinase Deficiency (Hallervorden-Spatz Disease),” Revista Espanola de Anestesiología y Reanimación, Vol. 56, No. 3, 2009, pp. 180-184.
|